The Lambda variant, originating in Peru, has been found in 32 countries - but for the moment, it remains classified as a less threatening Variant of Interest.
SAGE say the UK Governments' plans to lift all social distancing measures on 19 July are too much - they believe a rise in infections will increase ethnic minority COVID deaths.
The team will have results to discuss in April, 2022 - they nurse the hope that this HIV vaccine could stop different geographical strains, after 40 years of no cure.
While mRNA is now well-connected to Pfizer or Moderna, saRNA is a more obscure, early-stage vaccine technology - now, scientists in the UK have data suggesting that saRNA COVID vaccines could work well for most people.
Sally Bibb, strengths and talent expert, and Amanda Kelly, adult and children’s social care lead at PA Consulting, explore how the social care sector can be fixed by introducing a strengths-based approach to the recruitment process.
A study released yesterday (28 June) found that it would be safe to mix Pfizer and AstraZeneca doses, which could speed up UK vaccine roll-out if adopted.
Maternity safety minister Nadine Dorries has announced £2.45 million in funding for the NHS to improve the safety of women and babies during childbirth.
A study on New York City neighbourhoods found that "neighbourhood disadvantage", a mix of inequality measurements, is connected to a higher rate of COVID-19 cases.
Indiana University School of Medicine researchers are attempting to use magnetic nanoparticles to develop a cure for neurological disorders from epilepsy to Alzheimer's - without any invasive or genetic treatment.
The World Health Organisation says that double-vaccinated people should wear masks due to the rising threat of the Delta variant, as the UK considers dropping mandatory mask measures after 'unlockdown'.
The UK Government will begin rollout of a third COVID dose for over-50s and vulnerable individuals, with the NHS given the go-ahead to create their pre-winter vaccination plan.
According to the US and Swiss study, 94% of cancer patients took the COVID vaccine in full and produced antibodies - while seven high-risk patients failed to produce an immune response.
